[PHARMA] YoY Quarter Result on 31-Mar-2013 [#1]

Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- 412.21%
YoY- -13.64%
Quarter Report
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 559,195 471,904 468,672 500,339 446,745 385,328 317,560 9.88%
PBT 26,538 38,612 38,159 36,924 42,955 21,792 12,431 13.46%
Tax -8,068 -6,686 -11,513 -11,771 -13,894 -6,193 -3,122 17.12%
NP 18,470 31,926 26,646 25,153 29,061 15,599 9,309 12.08%
-
NP to SH 18,379 31,794 26,217 24,771 28,685 15,484 9,307 11.99%
-
Tax Rate 30.40% 17.32% 30.17% 31.88% 32.35% 28.42% 25.11% -
Total Cost 540,725 439,978 442,026 475,186 417,684 369,729 308,251 9.80%
-
Net Worth 515,906 528,173 515,022 484,829 474,161 437,661 439,675 2.69%
Dividend
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Div 10,354 18,123 10,352 8,825 8,824 - - -
Div Payout % 56.34% 57.00% 39.49% 35.63% 30.76% - - -
Equity
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Net Worth 515,906 528,173 515,022 484,829 474,161 437,661 439,675 2.69%
NOSH 258,859 258,908 258,805 117,676 117,657 107,007 106,977 15.85%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 3.30% 6.77% 5.69% 5.03% 6.51% 4.05% 2.93% -
ROE 3.56% 6.02% 5.09% 5.11% 6.05% 3.54% 2.12% -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 216.02 182.27 181.09 425.18 379.70 360.09 296.85 -5.15%
EPS 7.10 12.28 10.13 21.05 24.38 14.47 8.70 -3.32%
DPS 4.00 7.00 4.00 7.50 7.50 0.00 0.00 -
NAPS 1.993 2.04 1.99 4.12 4.03 4.09 4.11 -11.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 38.80 32.74 32.52 34.72 31.00 26.74 22.03 9.88%
EPS 1.28 2.21 1.82 1.72 1.99 1.07 0.65 11.94%
DPS 0.72 1.26 0.72 0.61 0.61 0.00 0.00 -
NAPS 0.358 0.3665 0.3573 0.3364 0.329 0.3037 0.3051 2.69%
Price Multiplier on Financial Quarter End Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 -
Price 5.76 6.00 4.46 8.26 5.90 5.73 4.27 -
P/RPS 2.67 3.29 2.46 1.94 1.55 1.59 1.44 10.82%
P/EPS 81.13 48.86 44.03 39.24 24.20 39.60 49.08 8.72%
EY 1.23 2.05 2.27 2.55 4.13 2.53 2.04 -8.07%
DY 0.69 1.17 0.90 0.91 1.27 0.00 0.00 -
P/NAPS 2.89 2.94 2.24 2.00 1.46 1.40 1.04 18.55%
Price Multiplier on Announcement Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 13/05/11 26/05/10 -
Price 5.60 6.91 4.70 9.26 5.90 5.05 4.71 -
P/RPS 2.59 3.79 2.60 2.18 1.55 1.40 1.59 8.46%
P/EPS 78.87 56.27 46.40 43.99 24.20 34.90 54.14 6.46%
EY 1.27 1.78 2.16 2.27 4.13 2.87 1.85 -6.07%
DY 0.71 1.01 0.85 0.81 1.27 0.00 0.00 -
P/NAPS 2.81 3.39 2.36 2.25 1.46 1.23 1.15 16.04%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment